Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials.

Saved in:
Bibliographic Details
Title: Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials.
Authors: Wakkerman FC; Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands., Wu J; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Putter H; Department of Biostatistics, Leiden University Medical Center, Leiden, Netherlands., Jürgenliemk-Schulz IM; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands., Jobsen JJ; Department of Radiotherapy, Medisch Spectrum Twente, Enschede, Netherlands., Lutgens LCHW; Maastricht Radiation Oncology Clinic, Maastricht, Netherlands., Haverkort MAD; Arnhem Radiotherapy Institute, Arnhem, Netherlands., de Jong MA; Radiotherapy Institute Friesland, Radiation Oncology, Leeuwarden, Netherlands., Mens JWM; Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Wortman BG; Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands., Nout RA; Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Léon-Castillo A; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands., Powell ME; Department of Clinical Oncology, Barts Health NHS Trust, London, UK., Mileshkin LR; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Katsaros D; Gynecology and Obstetrics, Departments of Surgical Sciences, City of Health and Science, University of Turin, Turin, Italy., Alfieri J; Division of Radiation Oncology, McGill University Health Centre, Montreal, QC, Canada., Leary A; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Singh N; Department of Pathology, Barts Health NHS Trust, London, UK., de Boer SM; Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands., Nijman HW; Department of Gynaecologic Oncology, University Medical Center Groningen, Groningen, Netherlands., Smit VTHBM; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands., Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands., Koelzer VH; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland., Creutzberg CL; Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands., Horeweg N; Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands. Electronic address: n.horeweg@lumc.nl.
Source: The Lancet. Oncology [Lancet Oncol] 2024 Jun; Vol. 25 (6), pp. 779-789. Date of Electronic Publication: 2024 Apr 30.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-5488
DOI:10.1016/S1470-2045(24)00142-6